13292-43-8 Usage
General Description
The chemical compound "(8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[(morpholin-4-ylamino)methylidene]-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate" is a complex organic molecule with a naphthofuran core structure. It contains multiple hydroxyl groups and a methoxy group, as well as a morpholine-4-ylamino and acetate functional groups. The compound also has several double bonds and a ring structure with oxygen atoms. The long and complex structure of the compound suggests that it may have pharmaceutical potential, as molecules with similar structures have been studied for their potential as anti-cancer, anti-inflammatory, or antimicrobial agents.
Check Digit Verification of cas no
The CAS Registry Mumber 13292-43-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,2,9 and 2 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 13292-43:
(7*1)+(6*3)+(5*2)+(4*9)+(3*2)+(2*4)+(1*3)=88
88 % 10 = 8
So 13292-43-8 is a valid CAS Registry Number.
13292-43-8Relevant articles and documents
Rifamycins as inhibitors of retroviral reverse transcriptase from M-MuLV, RAV-2, and HIV-1
Bartolucci,Cellai,Di Filippo,Segre,Brufani,Filocamo,Bianco,Guiso,Brizzi,Benedetto,Di Caro,Elia
, p. 1367 - 1383 (2007/10/02)
29 Rifamycins were tested for inhibition of Reverse Transcriptase (RT) as potential anti HIV drugs. Two purified commercial enzymes from M-MuLV and RAV-2 were used. Anti-RT activity was also measured on a crude lysate of HIV-1. The results show that some derivatives have interesting levels of activity on isolated M-MuLV and RAV-2 RTs, while they are less active on the RT in the crude HIV-1 lysate. The active derivatives include oximes and hydrazones, alkylaminoderivatives, open ansa-chain derivatives and derivatives carrying a modified nucleoside.
